Targinta AB
Developing targeted antibodies and ADCs for aggressive cancers.
Oversikt
- 0
- Ansatte
- ≤1t SEK
- Omsetning
- 2018
- Grunnlagt
Nøkkelbeslutningstakere
Evy Lundgren-Åkerlund
CEO
Beskrivelse
Targinta AB is a Swedish biotechnology company focused on developing novel treatments for aggressive and life-threatening cancers. The company specializes in creating targeted, toxin-armed antibodies, known as Antibody-Drug Conjugates (ADCs), and functional blocking antibodies. Their entire product...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559157669801
Beslutningstakere
1 kontakter i FunnelfeedrEvy Lundgren-Åkerlund
CEO
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Xintela AB
10–19 ansatteDeveloping stem cell and targeted cancer therapies for unmet needs.
Ascelia Pharma AB
Biotech developing novel orphan oncology drugs for unmet needs.
BioInvent International Aktiebolag
100–199 ansatteClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Ascelia Incentive AB
0 ansatteBiotech developing novel orphan oncology drugs for unmet medical needs.
Affibody Medical AB
Developing next-generation radiopharmaceuticals using proprietary Affibody platform.
Utforsk mer
Spørsmål om Targinta AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo